SOAT1 and psoriasis: In particular, phosphorylated and non-phosphorylated forms of JAK/STAT pathway members were analyzed in atopic dermatitis, psoriasis, lichen planus, cutaneous lupus erythematosus, pyoderma gangrenosum, and alopecia areata versus healthy controls.